Evidence map›Paper›PMID 21652649›Full record

ArticleDevelopment (Cambridge, England)2011

Direct targets of the D. melanogaster DSXF protein and the evolution of sexual development.

Shengzhan D Luo, Guang W Shi, Bruce S Baker

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Sexual dimorphism in the complete connectome of thebioRxiv : the preprint server for biology · 2025
    Article
  5. Evolution of sex determination in crustaceans.Marine life science & technology · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The Hox geneDevelopment (Cambridge, England) · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shengzhan D LuoBiology Department, Stanford University, Stanford, CA 94305, USA.
Guang W Shi
Bruce S Baker
Stanford University · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Uncovering the direct regulatory targets of doublesex (dsx) and fruitless (fru) is crucial for an understanding of how they regulate sexual development, morphogenesis, differentiation and adult functions (including behavior) in Drosophila melanogaster. Using a modified DamID approach, we identified 650 DSX-binding regions in the genome from which we then extracted an optimal palindromic 13 bp DSX-binding sequence. This sequence is functional in vivo, and the base identity at each position is important for DSX binding in vitro. In addition, this sequence is enriched in the genomes of D. melanogaster (58 copies versus approximately the three expected from random) and in the 11 other sequenced Drosophila species, as well as in some other Dipterans. Twenty-three genes are associated with both an in vivo peak in DSX binding and an optimal DSX-binding sequence, and thus are almost certainly direct DSX targets. The association of these 23 genes with optimum DSX binding sites was used to examine the evolutionary changes occurring in DSX and its targets in insects.

Indexed as

AnimalsBinding SitesDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsElectrophoretic Mobility Shift AssayFemaleGene Expression Regulation, DevelopmentalMaleProtein BindingSequence Analysis, DNASexual DevelopmentDNA-Binding ProteinsDrosophila ProteinsDSX protein, Drosophila

Identifiers

PMID21652649
PMCPMC3109601
OpenAlexW2091161122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.